From genetics to dietetics: The contribution of epidemiology to understanding Alzheimer's disease

Advances in Alzheimer's Disease

Volumn 3, Issue , 2012, Pages 457-463

  Barberger Gateau, Pascale ^a,b   Lambert, Jean Charles ^a,c,d   Féart, Catherine ^a,b   Pérès, Karine ^a,b   Ritchie, Karen ^a,e   Dartigues, Jean François ^a,b   Alpérovitch, Annick ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIV LILLE   (France)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Activities of daily living; Alzheimer's disease; caffeine; cohort studies; dementia; epidemiology; genome wide association study; Mediterranean diet

Indexed keywords

APOLIPOPROTEIN E; CAFFEINE; CLUSTERIN; OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; APOLIPOPROTEIN J GENE; ARTICLE; DAILY LIFE ACTIVITY; DIETARY COMPLIANCE; DIETARY RISK FACTOR; DIETETICS; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HIGH RISK PATIENT; HUMAN; MEDITERRANEAN DIET; MOLECULAR PATHOLOGY; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

EID: 84877999141     PISSN: 22105727     EISSN: 22105735     Source Type: Book Series    
DOI: 10.3233/978-1-61499-154-0-457     Document Type: Article

References (26)

1. Dartigues JF, Gagnon M, Barberger-Gateau P, Letenneur L, Commenges D, Sauvel C, Michel P, Salamon R (1992) The PAQUID epidemiological program on brain aging. Neuroepidemiology 11, 14-18.
2. Three-City Study Group (2003) Vascular factors and risk of dementia: Design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22, 316-325.
3. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, AlvarezV, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues J-F, Tzourio C, Gut I,Van BroeckhovenC, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 1094-1099.
4. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A (2007) Dietary patterns and risk of dementia: The Three-City cohort study. Neurology 69, 1921-1930.
5. Feart C, Samieri C, RondeauV, Amieva H, Portet F, Dartigues J-F, Scarmeas N, Barberger-Gateau P (2009) Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 302, 638-648.
6. Ritchie K, Carriere I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 69, 536-545.
7. Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P (2006) Restriction in complex activities of daily living in MCI: Impact on outcome. Neurology 67, 461-466.
8. Lambert J-C, Amouyel P (2011) Genetics of Alzheimer's disease: New evidences for an old hypothesis? Curr Opin Genet Dev 21, 295-301.
9. Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5, 649-658.
10. Joseph J, Cole G, Head E, Ingram D (2009) Nutrition, brain aging, and neurodegeneration. J Neurosci 29, 12795-12801.
11. Feart C, Samieri C, Barberger Gateau P (2010) Diet and Alzheimer's disease: New evidence from epidemiological studies. In: Recent Advances on Nutrition in the Prevention of Alzheimer's Disease, Ramassamy C, Bastianetto S, eds. Research Signpost/Transworld Research Network, Trivandrum, India, pp. 19-40.
12. Burdge GC, Calder PC (2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45, 581-597.
13. Schmitz G, Ecker J (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47, 147-155.
14. Cunnane SC, Plourde M, Pifferi F, B'egin M, F'eart C, Barberger-Gateau P (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239-256.
15. Barberger Gateau P, Samieri C, Feart C, Plourde M (2011) Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: Interaction with apolipoprotein E genotype. Curr Alzheimer Res 8, 479-491.
16. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 2599-2608.
17. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA (2006) Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59, 912-921.
18. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, J OB, Pasquier F, Robert P, Rossor M, Solloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
19. Feart C, Samieri C, Barberger-Gateau P (2010) Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 13, 14-18.
20. Tangney CC,KwasnyMJ, Li H,Wilson RS, EvansDA,Morris MC(2011) Adherence to aMediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr 93, 601-607.
21. Roberts RO, Geda YE, Cerhan JR, Knopman DS, Cha RH, Christianson TJH, Pankratz VS, Ivnik RJ, Boeve BF, O'Connor HM, Petersen RC (2010) Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriat Cogn Dis 29, 413-423.
22. ArendashGW, Cao C (2010) Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis 20(Suppl 1), S117-S126.
23. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin ML, Carriere I (2010) Caffeine, cognitive functioning, and white matter lesions in the elderly: Establishing causality from epidemiological evidence. J Alzheimers Dis 20(Suppl 1), S161-S166.
24. Barberger-Gateau P, Fabrigoule C, Helmer C, Rouch I, Dartigues JF (1999) Functional impairment in Instrumental Activities of Daily Living: An early clinical sign of dementia? J Am Geriatr Soc 47, 456-462.
25. Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF (1992) Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 40, 1129-1134.
26. Dubois B, Feldman H, Jacova C, Cummings J, Dekosky S, Barberger-Gateau P, Delacourte A, Frisoni G, Fox N, Galasko D, Gauthier S, Hampel H, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza L, Stern Y, Visser P, Scheltens P (2010) Revising the definition of Alzheimer's disease:Anewlexicon. Lancet Neurol 9, 1118-1127.